Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to IrinotecanValerie Lee, Judy Wang, Marianna Zahurak, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 12, 2014
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathologyDaoud Sie, Peter J F Snijders, Gerrit A Meijer, et al.
Cancer Cell|January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugsAstrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Advances in Therapy|October 17, 2018
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid TumoursRuth Plummer, Henk M Verheul, Filip Y F L De Vos, et al.
Oncotarget|October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effectEsther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Molecular Cancer Therapeutics|January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian CancerColin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Molecular Imaging and Biology|May 2, 2018
Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical ImagesYvonne W S Jauw, Dennis F Heijtel, Josée M Zijlstra, et al.
Cancer Cell|November 4, 2015
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer DiagnosticsMyron G Best, Nik Sol, Irsan Kooi, et al.
The American Journal of Surgical Pathology|July 9, 2019
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 ResultsSuzanne C van Es, Bert van der Vegt, Frederike Bensch, et al.
Oncotarget|June 7, 2018
<sup>89</sup>Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-bindingEmilie M J van Brummelen, Marc C Huisman, Linda J de Wit-van der Veen, et al.
Pageof 5